Mother and son jogging Mother and son jogging Mother and son jogging Mother and son jogging
News Releases

News Releases

Date Title and Summary
Toggle Summary Abbott Receives FDA Approval for Next-Generation MitraClip® Device to Treat People with Leaky Heart Valves
- Innovations designed to allow doctors to treat more types of cases and anatomies - MitraClip is the gold-standard minimally invasive alternative to open-heart surgery for people needing mitral valve repair - Mitral regurgitation, the most common heart valve disease, affects one in 10 adults over
Toggle Summary Abbott Announces Freedom 2 Save Program for Employees to Address Student Debt
- Two-Thirds of Millennials Aren't Saving for Retirement - Benefit Means Student Debt Won't Prevent Retirement Savings ABBOTT PARK, Ill., June 26, 2018 /PRNewswire/ -- Historic levels of student debt have forced many people to choose between saving for their futures and paying off school loans.
Toggle Summary New Late-Breaking Data at ADA Underscore Significant Benefits of Abbott's FreeStyle Libre System for People Living with Diabetes
- Expanded Real-World Evidence from More than 250,000 individuals using Freestyle libre system Showed Higher Frequency Scanning is Associated with improved glucose control, decreased glucose variability and reduced incidence of both daytime and nocturnal hypoglycemia - New meta-analysis showed for
Toggle Summary Abbott Hosts Conference Call for Second-Quarter Earnings
ABBOTT PARK, Ill., June 20, 2018 /PRNewswire/ --  Abbott (NYSE: ABT) will announce its second-quarter 2018 financial results on Wednesday, July 18, 2018 , before the market opens.  The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m.
Toggle Summary Abbott Declares 378th Consecutive Quarterly Dividend
ABBOTT PARK, Ill., June 8, 2018 /PRNewswire/ -- The board of directors of Abbott  (NYSE: ABT) today declared a quarterly common dividend of 28 cents per share. This marks the 378 th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Aug.
Toggle Summary Abbott Introduces the Afinion™ 2 Analyzer Rapid Test System for Diabetes Management
STATE-OF-THE-ART MULTI-ASSAY TEST SYSTEM HELPS PEOPLE WITH DIABETES GET THE HbA1c RESULTS THEY NEED WITHIN 3 MINUTES -- ALLOWING MORE TIME FOR CONSULTATION AND CARE DURING A SINGLE HEALTHCARE VISIT ABBOTT PARK, Ill., May 31, 2018 /PRNewswire/ --  Abbott (NYSE: ABT) announced today the launch of its
Toggle Summary Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease
- XIENCE Sierra™, the newest generation of XIENCE drug-eluting stents, received U.S. Food and Drug Administration (FDA) approval - XIENCE stents are among the most-widely used and studied stents in the world and have an unparalleled safety record - New features help doctors treat more
Toggle Summary Abbott's Investigational Tendyne™ Device for Mitral Valve Replacement Demonstrates Positive Outcomes at 30 Days in Global Study
- Promising results for Tendyne valve presented as late-breaking clinical trial at EuroPCR - Early data showed high rates of successful implantation and reduction of mitral regurgitation symptoms in patients in global study - Device will be further studied in U.S.
Toggle Summary Five-Year Study Data Confirm Positive Outcomes for Patients When Abbott Diagnostic Tool Was Used to Guide Heart Stenting Decisions
- Late-breaking data presented at EuroPCR and simultaneously published in "The New England Journal of Medicine" support use of Abbott's PressureWire™ guidewire to help physicians make stenting decisions - Stenting guided by Abbott's PressureWire diagnostic tool reduced major adverse coronary
Toggle Summary Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter
- ADVISOR™ HD GRID MAPPING CATHETER, SENSOR ENABLED™ FACILITATES IMPROVED DATA COLLECTION, SUPPORTING OPTIMAL TREATMENT FOR PATIENTS WITH COMPLEX CARDIAC ARRHYTHMIAS - FIRST-OF-ITS-KIND GRID CONFIGURATION IS DESIGNED TO CAPTURE DATA IN MULTIPLE DIRECTIONS TO CREATE HIGH-DENSITY MAPS OF THE HEART -